Harvard Bioscience, Inc. (HBIO)
NASDAQ: HBIO · Real-Time Price · USD
0.5798
-0.0112 (-1.90%)
Mar 3, 2026, 11:51 AM EST - Market open
Harvard Bioscience Analyst Ratings
Total Analysts
3
Consensus Rating
Buy
Price Target
$2.50
Upside
+331.18%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Benchmark | Benchmark | Buy Maintains $3 → $2 | Buy | Maintains | $3 → $2 | +244.95% | Sep 10, 2025 |
| Benchmark | Benchmark | Buy Maintains $4.5 → $3 | Buy | Maintains | $4.5 → $3 | +417.42% | May 13, 2025 |
| Keybanc | Keybanc | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Apr 9, 2025 |
| Benchmark | Benchmark | Buy Maintains $5.5 → $4.5 | Buy | Maintains | $5.5 → $4.5 | +676.13% | Mar 24, 2025 |
| Benchmark | Benchmark | Buy Reiterates $7 | Buy | Reiterates | $7 | +1,107.31% | Jun 22, 2023 |
| Benchmark | Benchmark | Strong Buy Maintains $4 → $7 | Strong Buy | Maintains | $4 → $7 | +1,107.31% | Apr 26, 2023 |
| Keybanc | Keybanc | Buy Maintains $5 → $7 | Buy | Maintains | $5 → $7 | +1,107.31% | Apr 26, 2023 |
| Benchmark | Benchmark | Strong Buy Reiterates $4 | Strong Buy | Reiterates | $4 | +589.89% | Mar 10, 2023 |
| Keybanc | Keybanc | Buy Maintains $7 → $5 | Buy | Maintains | $7 → $5 | +762.37% | Nov 9, 2022 |
| Keybanc | Keybanc | Buy Maintains $10 → $7 | Buy | Maintains | $10 → $7 | +1,107.31% | Aug 5, 2022 |
| Keybanc | Keybanc | Buy Initiates $6 | Buy | Initiates | $6 | +934.84% | Nov 10, 2020 |
| Benchmark | Benchmark | Buy Maintains $3.5 → $4 | Buy | Maintains | $3.5 → $4 | +589.89% | Feb 27, 2020 |
| Benchmark | Benchmark | Strong Buy Initiates $8 | Strong Buy | Initiates | $8 | +1,279.79% | Jul 28, 2015 |